A
Akinobu Ito
Researcher at Hokkaido University
Publications - 18
Citations - 1377
Akinobu Ito is an academic researcher from Hokkaido University. The author has contributed to research in topics: Biofilm & Escherichia coli. The author has an hindex of 10, co-authored 17 publications receiving 1014 citations.
Papers
More filters
Journal ArticleDOI
Increased Antibiotic Resistance of Escherichia coli in Mature Biofilms
TL;DR: It is likely that the observed resistance of bioFilms can be attributed to formation of ampicillin-resistant subpopulations in the deeper layers of mature biofilms but not in young colony biofilm and that the production and resistance of the subpopulation were aided by biofilm-specific phenotypes, like slow growth and induction of rpoS-mediated stress responses.
Journal ArticleDOI
Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa
Akinobu Ito,Toru Nishikawa,Shuhei Matsumoto,Hidenori Yoshizawa,Takafumi Sato,Rio Nakamura,Masakatsu Tsuji,Yoshinori Yamano +7 more
TL;DR: It is concluded that cefIDERocol forms a chelating complex with iron, which is actively transported into P. aeruginosa cells via iron transporters, resulting in potent antibacterial activity of cefiderocol against P.aerug inosa.
Journal ArticleDOI
In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria
Akinobu Ito,Takafumi Sato,Merime Ota,Miki Takemura,Toru Nishikawa,Shinsuke Toba,Naoki Kohira,Satoshi Miyagawa,Naoki Ishibashi,Shuhei Matsumoto,Rio Nakamura,Masakatsu Tsuji,Yoshinori Yamano +12 more
TL;DR: Cefiderocol, a novel parenteral siderophore cephalosporin conjugated with a catechol moiety, has a characteristic antibacterial spectrum with a potent activity against a broad range of aerobic Gram-negative bacterial species, including carbapenem-resistant strains of Enterobacteriaceae and nonfermenting bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii.
Journal ArticleDOI
In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
Naoki Kohira,Joshua West,Akinobu Ito,Tsukasa Ito-Horiyama,Rio Nakamura,Takafumi Sato,Stephen Rittenhouse,Masakatsu Tsuji,Yoshinori Yamano +8 more
TL;DR: This is the first report to demonstrate that S-649266, a novel siderophore cephalosporin, has significant antimicrobial activity against Enterobacteriaceae, including strains that produce carbapenemases such as KPC and NDM-1.
Journal ArticleDOI
Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
Tsukasa Ito-Horiyama,Yoshikazu Ishii,Akinobu Ito,Takafumi Sato,Rio Nakamura,Norio Fukuhara,Masakatsu Tsuji,Yoshinori Yamano,Keizo Yamaguchi,Kazuhiro Tateda +9 more
TL;DR: Its stability against clinically relevant carbapenemases was investigated and NDM-1 hydrolyzed meropenem 3-fold faster than S-649266 at 200 μM.